From: Six-month survival and quality of life of intensive care patients with acute kidney injury
 | EQ-5D index | EQ-5D VAS | ||
---|---|---|---|---|
 | Study patients | General population | Study patients | General population |
All study patients (N = 959) | 0.690 (0.533-1.00)a | 0.845 (0.812-0.882) | 73 (59–85) | 70 (68–77) |
No AKI patients (N = 632) | 0.690 (0.533-1.00)a | 0.845 (0.812-0.882) | 75 (60–87) | 70 (68–77) |
AKI patients (N = 327) | 0.676 (0.520-1.00)a | 0.826 (0.812-0.859) | 70 (50–83) | 69 (68–73) |
Stage 1 (N = 148) | 0.691 (0.534-1.00)a | 0.826 (0.812-0.876) | 75 (60–86) | 69 (68–76) |
Stage 2 (N = 65) | 0.631 (0.442-0.795)a | 0.826 (0.774-0.859) | 69 (50–82) | 69 (65–73) |
Stage 3 (N = 114) | 0.676 (0.486-1.00)a | 0.845 (0.826-0.859) | 70 (50–80) | 70 (68–73) |
With RRT (of stage 3) (N = 85) | 0.676 (0.482-0.802)a | 0.845 (0.819-0.882) | 65 (50–80)a | 70 (68–77) |
Without RRT (of stage 3) (N = 29) | 0.676 (0.504-1.00) | 0.826 (0.826-0.852) | 70 (50–90) | 68 (68–73) |